The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy
- PMID: 15147877
- DOI: 10.1016/j.febslet.2004.04.013
The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy
Abstract
Hereditary inclusion body myopathy (HIBM) is a neuromuscular disorder, caused by mutations in UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, the key enzyme of sialic acid biosynthesis. In Middle Eastern patients a single homozygous mutation occurs, converting methionine-712 to threonine. Recombinant expression of the mutated enzyme revealed slightly reduced N-acetylmannosamine kinase activity, in agreement with the localization of the mutation within the kinase domain. B lymphoblastoid cell lines derived from patients expressing the mutated enzyme also display reduced UDP-N-acetylglucosamine 2-epimerase activity. Nevertheless, no reduced cellular sialylation was found in those cells by colorimetric assays and lectin analysis, indicating that HIBM is not directly caused by an altered overall expression of sialic acids.
Similar articles
-
Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy.Glycobiology. 2005 Nov;15(11):1102-10. doi: 10.1093/glycob/cwi100. Epub 2005 Jun 29. Glycobiology. 2005. PMID: 15987957
-
Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.Biol Chem. 2001 Feb;382(2):291-7. doi: 10.1515/BC.2001.036. Biol Chem. 2001. PMID: 11308027
-
Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.Biochemistry. 2006 Mar 7;45(9):2968-77. doi: 10.1021/bi0522504. Biochemistry. 2006. PMID: 16503651
-
Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis.Biol Chem. 2009 Jul;390(7):591-9. doi: 10.1515/BC.2009.073. Biol Chem. 2009. PMID: 19426133 Review.
-
The hereditary inclusion body myopathy enigma and its future therapy.Neurotherapeutics. 2008 Oct;5(4):633-7. doi: 10.1016/j.nurt.2008.07.004. Neurotherapeutics. 2008. PMID: 19019317 Free PMC article. Review.
Cited by
-
Generation and characterization of a novel gne Knockout Model in Zebrafish.Front Cell Dev Biol. 2022 Oct 24;10:976111. doi: 10.3389/fcell.2022.976111. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36353515 Free PMC article.
-
GNE myopathy: a personal trip from bedside observation to therapeutic trials.Acta Myol. 2014 Oct;33(2):107-10. Acta Myol. 2014. PMID: 25709382 Free PMC article.
-
Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.PLoS One. 2010 Apr 7;5(4):e10055. doi: 10.1371/journal.pone.0010055. PLoS One. 2010. PMID: 20383336 Free PMC article.
-
Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy.Curr Neurol Neurosci Rep. 2005 Feb;5(1):61-5. doi: 10.1007/s11910-005-0025-0. Curr Neurol Neurosci Rep. 2005. PMID: 15676110 Review.
-
Correction of the Middle Eastern M712T mutation causing GNE myopathy by trans-splicing.Neuromolecular Med. 2014 Jun;16(2):322-31. doi: 10.1007/s12017-013-8278-2. Epub 2013 Nov 22. Neuromolecular Med. 2014. PMID: 24264357
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
